2008
DOI: 10.1038/leu.2008.204
|View full text |Cite
|
Sign up to set email alerts
|

Rapamycin reverses NPM-ALK-induced glucocorticoid resistance in lymphoid tumor cells by inhibiting mTOR signaling pathway, enhancing G1 cell cycle arrest and apoptosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
32
0

Year Published

2009
2009
2015
2015

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 39 publications
(37 citation statements)
references
References 29 publications
5
32
0
Order By: Relevance
“…11 Recently, aberrations in the activation of the mTOR-signaling pathway have come to light in NHL. 12,13 An in vivo model using the mTOR inhibitor CCI-779 demonstrated apoptosis and growth suppression of primary acute lymphocytic lymphoma cells engrafted in nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mice, 14 providing a strong rationale for the development of mTOR-targeted therapy in lymphoid malignancies. Therefore, improved understanding of the underlying molecular mechanism(s) associated with the ability of ethanol to suppress mTOR activity may form the basis for the development of innovative approaches to prevent lymphoma growth.…”
Section: Introductionmentioning
confidence: 99%
“…11 Recently, aberrations in the activation of the mTOR-signaling pathway have come to light in NHL. 12,13 An in vivo model using the mTOR inhibitor CCI-779 demonstrated apoptosis and growth suppression of primary acute lymphocytic lymphoma cells engrafted in nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mice, 14 providing a strong rationale for the development of mTOR-targeted therapy in lymphoid malignancies. Therefore, improved understanding of the underlying molecular mechanism(s) associated with the ability of ethanol to suppress mTOR activity may form the basis for the development of innovative approaches to prevent lymphoma growth.…”
Section: Introductionmentioning
confidence: 99%
“…mTOR can participate in the regulation of neuronal death. mTOR inhibition by rapamycin can suppress the activation of cyclin-dependent kinases and then inhibits the cell cycle progress, suppresses cell proliferation, and fi nally results in cell apoptosis (Gu et al 2008 ).…”
Section: Hypoxic-ischemic Brain Damage and Tryptophanmentioning
confidence: 99%
“…mTOR, c-Jun, nuclear interacting partner of ALK (NIPA), and AKT) (13,18,19). It is highly possible that NPM-ALK induces serine/threonine phosphorylation of downstream targets through recruitment and activation of various serine/ threonine kinases like previously reported JNK and ERK (12,18).…”
Section: Molecular and Cellular Proteomics 9:1616 -1632 2010mentioning
confidence: 99%
“…NPM-ALK has been shown to have propensity to dimerize, and this process triggers autophosphorylation of NPM-ALK and results in constitutive activation of the ALK tyrosine kinase. Once activated, NPM-ALK binds, phosphorylates, and constitutively activates a host of proteins involved in various cellular signaling pathways, including those of PI3K/RAC-␣ serine/threonine-protein kinase (AKT) (8,9), JAK/STAT (10), mTOR (11)(12)(13), mitogen-activated protein kinase/extracellular signal-regulated kinase kinase (MEK)/ERK (14), and Ras/ MAPK (15).…”
Section: Molecular and Cellular Proteomics 9:1616 -1632 2010mentioning
confidence: 99%